OVFTP Cancer Treatment: FIGO’s 2018 Summary

from Dr. Chapa’s OBGYN Clinical Pearls · host Dr. Chapa’s Clinical Pearls

In our previous episode, we covered the revised FIGO ovarian cancer staging which now includes fallopian tube and peritoneal malignancies. In this episode, we will cover the FIGO guidelines regarding the management of OVFTP cancer. What role do PARP inhibitors play? Does treatment for asymptotic recurrence based on CA125 help? Can tamoxifen be used in recurrent malignancy? Let’s find out… Now.

Episode metadata supplied by the publisher feed · Published Oct 5, 2019

Embed this episode

Attribution link and audio player

NOW PLAYING

OVFTP Cancer Treatment: FIGO’s 2018 Summary

0:00 12:22

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Dr. Chapa’s OBGYN Clinical Pearls?

This episode is 12 minutes long.

When was this Dr. Chapa’s OBGYN Clinical Pearls episode published?

This episode was published on October 5, 2019.

Can I download this Dr. Chapa’s OBGYN Clinical Pearls episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!